Delaware Imaging Network Adds Breast Cancer Risk Scores During Annual Screening Mammograms, Paving Way for Personalized Breast Cancer Screening
21 juin 2019 10h00 HE
|
RadNet, Inc.
NEWARK, Del., June 21, 2019 (GLOBE NEWSWIRE) -- Delaware Imaging Network (DIN) has announced personalized breast cancer risk assessment during annual mammographic screenings. DIN, a wholly owned...
New Features in Exa Mammo Designed to Address Quality Assurance and Improve Communication
03 avr. 2019 09h00 HE
|
Konica Minolta Healthcare Americas, Inc.
WAYNE, N.J., April 03, 2019 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc., will highlight new features of Exa® Mammo, a PACS designed for breast imaging centers. Exa Mammo enables...
Medical Image Management Market Worth $4.89 Billion by 2024- Exclusive Report by Meticulous Research®
04 déc. 2018 09h47 HE
|
Meticulous Market Research Pvt. Ltd.
LONDON, Dec. 04, 2018 (GLOBE NEWSWIRE) -- According to this latest publication from Meticulous Research®, the global medical image management market is expected to grow at a CAGR of 7.7% from 2018...
Breast Cancer Companion Diagnostics to Surpass $1B by 2022
30 mai 2018 16h45 HE
|
BCC Research
WELLESLEY, Mass., May 30, 2018 (GLOBE NEWSWIRE) -- The need for safer, more efficacious drugs and better diagnostic tools is driving growth in the global market for breast cancer diagnostics and...
PDC Healthcare Introduces New Line of Spee-D-Mark™ 3D Breast Tomosynthesis Markers for Mammography
31 oct. 2017 10h00 HE
|
PDC
VALENCIA, Calif., Oct. 31, 2017 (GLOBE NEWSWIRE) -- PDC Healthcare, a global leader of innovative identification and patient safety solutions, announced today the release of its new line of...
CONTEMPORARY OBSTETRICS AND GYNECOLOGY OF DAYTON ANNOUNCES THE AVAILABILITY OF STATE-OF-THE-ART BREAST CANCER RISK ASSESSMENT TEST
30 sept. 2013 10h34 HE
|
Genetic Technologies Group
DAYTON, Ohio, Sept. 30, 2013 (GLOBE NEWSWIRE) -- Contemporary Obstetrics & Gynecology, part of the Providence Medical Group, today announced the availability of the BREVAGen™ predictive risk...
PEARL W. YEE, M.D. INC. OF SAN FRANCISCO ANNOUNCES THE AVAILABILITY OF STATE-OF-THE-ART BREAST CANCER RISK ASSESSMENT TEST
16 sept. 2013 10h08 HE
|
Genetic Technologies Group
SAN FRANCISCO, Sept. 16, 2013 (GLOBE NEWSWIRE) -- Pearl Yee, MD, FACOG and clinical professor at the University of California, San Francisco, is pleased to announce that her private practice, Pearl W....
OB/GYN ASSOCIATES IN LEWISBURG, PA ANNOUNCES THE AVAILABILITY OF STATE-OF-THE-ART BREAST CANCER RISK ASSESSMENT TEST
26 août 2013 13h06 HE
|
Genetic Technologies Group
SUNBURY, PA., Aug. 26, 2013 (GLOBE NEWSWIRE) -- Russell Stankiewicz, MD, FACOG, CCD, NMCP, is pleased to announce that OB/GYN Associates of Lewisburg, P.C. in Lewisburg, PA is now offering the...
THE HEWITT CENTER FOR BREAST WELLNESS AT GRIFFIN HOSPITAL IN DERBY, CT LAUNCHES HIGH-RISK PROGRAM INCLUDING STATE-OF-THE-ART BREAST CANCER SCREENING OPTIONS
24 juin 2013 12h16 HE
|
Genetic Technologies Group
DERBY, Conn., June 24, 2013 (GLOBE NEWSWIRE) -- Denise Barajas, MD, medical director at The Hewitt Center for Breast Wellness in Derby, CT, has launched a high-risk breast cancer program that includes...
Atossa Genetics Signs Distribution Agreement With Fisher HealthCare
20 juin 2013 08h00 HE
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Jun 20, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, has signed an agreement with Fisher HealthCare Inc., part of Thermo Fisher...